4 citations
,
August 2022 in “Aesthetic Surgery Journal” This study found that one session of intradermal botulinum toxin type A injection decreased scalp sebum secretion and perception of greasiness more effectively than saline for up to 3 months.
2 citations
,
July 2022 in “Dermatologic Therapy” This study concluded that both botulinum toxin A and multivitamins mesotherapy effectively treat telogen effluvium, but a single botulinum toxin A session may be preferable due to its convenience and comparable efficacy.
June 2022 in “Journal of Cosmetic Dermatology” This study found that combining botulinum toxin A injections with finasteride and minoxidil increased hair density in patients with androgenic alopecia more effectively than finasteride and minoxidil alone.
8 citations
,
March 2022 in “Dermatologic Therapy” This article provides information on data availability but reports no new research findings.
3 citations
,
January 2022 in “Journal of Cosmetic Dermatology” This study found that for treating androgenetic alopecia, LC hair essence serum injections provided excellent results with fewer side effects compared to botulinum toxin A, which also showed significant efficacy but with higher associated costs and more frequent side effects.
15 citations
,
April 2020 in “Journal of The American Academy of Dermatology” In this study, intradermal injection of botulinum toxin was associated with increased hair growth in men with androgenetic alopecia through the suppression of TGF-β1 secretion from dermal papilla cells.
11 citations
,
January 2019 in “Skin appendage disorders” This article reports a case of a 30-year-old woman developing alopecia after a hyaluronic acid injection, with trichoscopic findings described for the first time.
24 citations
,
January 2017 in “Journal of Cutaneous and Aesthetic Surgery” In this pilot study, botulinum toxin was found to be a safe and effective treatment for androgenetic alopecia in most participants, though larger studies are needed to confirm these findings.
15 citations
,
May 2013 in “Ophthalmic Plastic and Reconstructive Surgery” In this case study, repetitive botulinum type A toxin injections led to almost complete resolution of severe chronic pain in a patient with Parry-Romberg syndrome.
19 citations
,
March 2013 in “Headache The Journal of Head and Face Pain” This case report describes a 33-year-old woman whose unilateral occipital pain and localized alopecia were only responsive to onabotulinumtoxin A, suggesting it might be a form of cephalalgia alopecia or nummular headache.
24 citations
,
December 2010 in “Dermatologic surgery” In this study, BTXA injections did not effectively treat recalcitrant alopecia areata or improve hair regrowth in most patients, suggesting its limitations as an alternative therapy.
50 citations
,
November 2010 in “Plastic and Reconstructive Surgery” This study suggests that Botox injections may increase hair count and reduce hair loss in men with androgenetic alopecia, potentially through increased blood flow and oxygen to the scalp.
26 citations
,
April 2006 in “Cephalalgia” Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.